ArticleFrontiers in medicine2026
GA-TAN: a graph aggregation and topology-aware network for unified 3D ocular-cerebral vascular segmentation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The eye and brain share developmental and regulatory vascular similarities, and 3D vascular segmentation from Optical Coherence Tomography Angiography (OCTA) and Magnetic Resonance Angiography (MRA) is essential for neuro-ophthalmic assessment. However, vascular trees exhibit extreme multi-scale morphology and are vulnerable to topology disruptions caused by OCTA artifacts (e.g., noise and discontinuities) and MRA anatomical variants (e.g., Circle of Willis incompleteness), which often lead to fragmented vessels and unstable segment-wise predictions. Purpose: To develop a unified 3D vascular segmentation framework that transfers and shares structural priors across OCTA and MRA, enabling accurate parsing under extreme scale imbalance and topology disruptions, and producing anatomically plausible predictions that remain robust to imaging artifacts in OCTA and Circle-of-Willis variants in MRA. Methods: We propose GA-TAN, a Graph Aggregation and Topology-Aware Network for unified ocular-cerebral vascular segmentation. GA-TAN employs a variable-window hybrid CNN-Transformer backbone to adapt receptive fields across vessel scales, an Efficient Multi-Scale Attention (EMA) module to enhance volumetric spatial-channel interactions, and a Multi-Scale Graph Aggregation (MSGA) module to perform global topological reasoning and hierarchical feature fusion. A topology-aware training objective further supervises segment existence and connectivity to penalize structural discontinuities beyond pixel-wise losses. Experiments were conducted on Retina3D for binary 3D OCTA vessel segmentation and on TopCow for 13-class CoW artery segmentation from MRA. Results: GA-TAN achieved the best overall performance on Retina3D, with a DSC of 0.684 and a clDice of 0.667, indicating improved overlap accuracy and centerline connectivity preservation. On TopCow, GA-TAN obtained a mean Dice of 0.814 across 13 arterial categories and produced more anatomically consistent segment-wise predictions, showing clear advantages on thin communicating and variant-related segments. Ablation studies further validated the complementary contributions of EMA, MSGA, and topology-aware supervision. Conclusion: GA-TAN provides a unified and topology-aware solution for 3D vascular segmentation across OCTA and MRA. By integrating adaptive multi-scale modeling, graph-based global aggregation, and explicit topology supervision, the proposed framework improves both segmentation accuracy and vascular ontinuity, enhancing robustness to imaging artifacts and anatomical variants for ocular-cerebral vascular analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.